HEPACAM and myeloid sarcoma: It is also worth noting that higher titers of anti-GlialCAM antibodies are found in MS individuals and have been indicated as likely contributors to MS pathogenesis due to the molecular mimicry between GlialCAM and EBNA1 produced by Epstein-Barr virus (Lanz et al., 2022).